StonvexLoading…
StonvexStonvexStonvexCore line items from RMTI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $69.26M | $101.49M | $83.61M | $72.81M |
Operating Income | $-4.69M | $608.00K | $-6.67M | $-16.78M |
Net Income | $-5.31M | $-480.00K | $-8.44M | $-18.68M |
EPS (Diluted) | $-0.15 | $-0.03 | $-0.37 | $-1.31 |
Total Assets | $57.15M | $59.21M | $52.17M | $46.63M |
Total Liabilities | $20.16M | $26.62M | $30.88M | $32.53M |
Cash & Equivalents | $10.71M | $15.66M | $8.98M | $10.10M |
Free Cash Flow OCF − CapEx | $-1.20M | $3.19M | $-9.70M | $-17.21M |
Shares Outstanding | 39.41M | 34.06M | 29.13M | 12.16M |